(NASDAQ: WGS) Genedx Holdings's forecast annual revenue growth rate of 24.29% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 8.63%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.05%.
Genedx Holdings's revenue in 2026 is $442,678,000.On average, 11 Wall Street analysts forecast WGS's revenue for 2026 to be $16,498,230,364, with the lowest WGS revenue forecast at $15,856,375,221, and the highest WGS revenue forecast at $17,346,417,296. On average, 11 Wall Street analysts forecast WGS's revenue for 2027 to be $20,775,087,534, with the lowest WGS revenue forecast at $18,911,273,199, and the highest WGS revenue forecast at $22,765,372,864.
In 2028, WGS is forecast to generate $25,284,698,835 in revenue, with the lowest revenue forecast at $21,916,592,172 and the highest revenue forecast at $29,717,715,027.